Thrombolysis in Special Situations

  • Carlos Jerjes-SánchezEmail author
  • Anabel Garcia-Sosa


Physicians treating acute pulmonary embolism take decisions based on current guidelines and recommendations; however in specific conditions as in-transit thrombus and pregnant women, specific guidance from recent guidelines may be absent; furthermore if activated factors oral anticoagulants could be used as adjunctive treatment in PE patients submitted to thrombolysis is an open question. In this chapter a review of the evidence in these specific clinical conditions was performed.


Thrombolysis Thrombus-in-transit Pregnancy Factor-specific oral anticoagulants 


  1. 1.
    Kronik G. The European Cooperative Study on the clinical significance of right heart thrombi, European Working Group on Echocardiography. Eur Heart J. 1989;10:1046–59.Google Scholar
  2. 2.
    Begieneman MVP, Van de Goot FRW, Van der Bilt IAC, Vonk Noordegraaf C, Spreeuwenberg MD, Paulus WJ, Van Hinsbergh VWM, Visser FC, Niessen HWM. Pulmonary embolism causes endomyocarditis in the human heart. Heart. 2008;94:450–6.CrossRefPubMedGoogle Scholar
  3. 3.
    Goldhaber SZ. Echocardiography in the management of pulmonary embolism. Ann Intern Med. 2002;136:691–700.CrossRefPubMedGoogle Scholar
  4. 4.
    Ogren M, Bergqvist D, Eriksson H, Lindblad B, Sternby NH. Prevalence and risk of pulmonary embolism in patients with intracardiac thrombosis: a population-based study of 23796 consecutive autopsies. Eur Heart J. 2005;26:1108–14.CrossRefPubMedGoogle Scholar
  5. 5.
    Goldhaber SZ, Visani L, De Rosa M. Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER). Lancet. 1999;353:1386–9.CrossRefPubMedGoogle Scholar
  6. 6.
    Torbicki A, Galié N, Covezzoli A, Rossi E, De la Rosa M, Golldhaber SZ. Right heart thrombi in pulmonary embolism: results from the International Cooperative Pulmonary Registry (ICOPER). J Am Coll Cardiol. 2003;41:2245–51.CrossRefPubMedGoogle Scholar
  7. 7.
    Chapoutot L, Nazeyrollas P, Metz D, Maes D, Maillier B, Jennesseaux C, Elaerts J. Floating right heart thrombi and pulmonary embolism: diagnosis, outcome and therapeutic management. Cardiology. 1996;87:169–74.CrossRefPubMedGoogle Scholar
  8. 8.
    Labovitz AJ, Noble VE, Bierig M, Goldstein SA, Jones R, Kort S, Porter TR, Spencer KT, Tayal VS, Wei K. Focused cardiac ultrasound in the emergent setting: a consensus statement of the American Society of Echocardiography and American College of Emergency Physicians. J Am Soc Echocardiogr. 2010;23:1225–30.CrossRefPubMedGoogle Scholar
  9. 9.
    Pierre-Justin P, Pierard L. Management of mobile right heart thrombi: a prospective series. Int J Cardiol. 2005;99:381–8.CrossRefPubMedGoogle Scholar
  10. 10.
    Chartier L, Bera J, Delomez M, Asseman P, Beregi JP, Bauchart JJ, Warembourg H, Théry C. Free-floating thrombi in the right heart: diagnosis, management, and prognostic indexes in 38 consecutive patients. Circulation. 1999;99:2779–83.CrossRefPubMedGoogle Scholar
  11. 11.
    Mohan B, Chhhabra S, Gulati A, Mittal C, Mohan G, Tandon R, Kumbkarni S, Aslam N, Soodnk NK, Wander GS. Clinical and echocardiographic diagnosis, follow-up and management of right sided cardiac thrombi. Indian Heart J. 2013;65:529–35.PubMedCentralCrossRefPubMedGoogle Scholar
  12. 12.
    Mollazadeh R, Ostovan MA, Abdi Ardekani AR. Right cardiac thrombus in transit among patients with pulmonary thromboemboli. Clin Cardiol. 2009;32:E27–31.CrossRefPubMedGoogle Scholar
  13. 13.
    Casazza F, Bongarzoni A, Centonze F, Morpurgo M. Prevalence and prognostic significance of right-sided cardiac mobile thrombi in acute massive pulmonary embolism. Am J Cardiol. 1997;79:1433–5.CrossRefPubMedGoogle Scholar
  14. 14.
    Rose PS, Punjabi NM, Pearse DB. Treatment of right heart thromboemboli. Chest. 2002;121:806–14.CrossRefPubMedGoogle Scholar
  15. 15.
    Konstantinides SV, Torbicki A, Agnelli G, Danchin N, Fitzmaurice D, Galie N, Gibbs JSR, Huisman MV, Humbert M, Kucher N, Lang I, Lankeit M, Lekakis J, Maack C, Mayer E, Meneveau N, Perrier A, Pruszczyk P, Rasmussen LH, Schindler TH, Svitil P, Noordegraaf AV, Zamorano JL, Zompatori M. 2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism. The Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC). Eur Heart J. 2014;35:3033–80. doi: 10.1093/eurheartj/ehu283.CrossRefPubMedGoogle Scholar
  16. 16.
    Jaff MR, McMurtry MS, Archer SL, Cushman M, Goldenberg NA, Goldhaber SZ, Jenkins JS, Kline JA, Michaels AD, Thistlethwaite P, Vedantham S, White RJ, Zierler BK, On behalf of the American Heart Association Council on Cardiopulmonary, Critical Care, Perioperative and Resuscitation, Council on Peripheral Vascular Disease, and Council on Arteriosclerosis, Thrombosis and Vascular Biology. Management of massive and submassive pulmonary embolism, iliofemoral deep vein thrombosis, and chronic thromboembolic pulmonary hypertension: a scientific statement from the American Heart Association. Circulation. 2011;123:1788–830. doi: 10.1161/CIR.0b013e318214914f.CrossRefPubMedGoogle Scholar
  17. 17.
    Konstantinides S, Geibel A, Olschewski M, Heinrich F, Grosser K, Rauber K, Iversen S, Redecker M, Kienast J, Just H, Kasper W. Association between thrombolytic treatment and the prognosis of hemodynamically stable patients with major pulmonary embolism: results of a multicenter registry. Circulation. 1997;96:882–8.CrossRefPubMedGoogle Scholar
  18. 18.
    Arcasoy SM, Kreit JW. Thrombolytic therapy of pulmonary embolism. Chest. 1999;115:1695–707.CrossRefPubMedGoogle Scholar
  19. 19.
    Chatterjee S, Chakraborty A, Weinberg I, Kadakia M, Wilensky RL, Sardar P, Kumbhani DJ, Mukherjee D, Jaff MR, Giri J. Thrombolysis for pulmonary embolism and risk of all-cause mortality, major bleeding, and intracranial hemorrhage a meta-analysis. JAMA. 2014;311:2414–21.CrossRefPubMedGoogle Scholar
  20. 20.
    Ferrari E, Benhamou M, Berthier F, Baudouy M. Mobile thrombi of the right heart in pulmonary embolism: delayed disappearance after thrombolytic therapy. Chest. 2005;121:1051–3.CrossRefGoogle Scholar
  21. 21.
    Greco F, Bisignani G, Serafini O, Guzzo D, Stingone A, Plastina F. Successful treatment of right heart thromboemboli with IV recombinant tissue-type plasminogen activator during continuous echocardiographic monitoring: a case series report. Chest. 1999;116:78–82.CrossRefPubMedGoogle Scholar
  22. 22.
    Myers PO, Bounameaux H, Panos A, Lerch R, Kalangos A. Impending paradoxical embolism: systematic review of prognostic factors and treatment. Chest. 2010;137:164–70.CrossRefPubMedGoogle Scholar
  23. 23.
    Thomppson T, Evans W. Paradoxical embolism. QJM. 1930;23:135–50.CrossRefGoogle Scholar
  24. 24.
    Meacham III RR, Headley AS, Bronze MS, Lewis JB, Rester MM. Impending paradoxical embolism. Arch Intern Med. 1998;158:438–48.CrossRefPubMedGoogle Scholar
  25. 25.
    Meier B, Lock JE. Contemporary management of patent foramen ovale. Circulation. 2003;107:5–9.CrossRefPubMedGoogle Scholar
  26. 26.
    Doyen D, Castellani M, Moceri P, Chiche O, Lazdunski R, Bertora D, Cerboni P, Chaussade C, Ferrari E. Patent foramen ovale and stroke in intermediate-risk pulmonary embolism. Chest. 2014;146:967–73.CrossRefPubMedGoogle Scholar
  27. 27.
    Leacche M, Unic D, Goldhaber SZ, Rawn JD, Aranki SF, Couper GS, Mihaljevic T, Rizzo RJ, Cohn LH, Aklog L, Byrne JG. Modern surgical treatment of massive pulmonary embolism: results in 47 consecutive patients after rapid diagnosis and aggressive surgical approach. J Thorac Cardiovasc Surg. 2005;129:1018–23.CrossRefPubMedGoogle Scholar
  28. 28.
    Major WK, Embolism P. Review of a pathophysiologic approach to the golden hour of hemodynamically significant pulmonary embolism. Chest. 2002;121:877–905.CrossRefGoogle Scholar
  29. 29.
    PIOPED Investigators. Value of the ventilation/perfusion scan in acute pulmonary embolism: results of the prospective investigation of pulmonary embolism diagnosis (PIOPED). JAMA. 1990;263:2753–9.CrossRefGoogle Scholar
  30. 30.
    Kuo WT, Gould MK, Louie JD, Rosenberg JK, Sze DY, Hofmann LV. Catheter directed therapy for the treatment of massive pulmonary embolism: systematic review and meta-analysis of modern techniques. J Vasc Interv Radiol. 2009;20:1431–40.CrossRefPubMedGoogle Scholar
  31. 31.
    The ATLANTIS. ECASS, and NINDS rt-PA Study Group Investigators Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet. 2004;363:768–74.CrossRefGoogle Scholar
  32. 32.
    Conti E, Zezza L, Ralli E, Comito C, Sada L, Passerini J, Caserta D, Rubattu S, Autore C, Moscarini M, Volpe M. Pulmonary embolism pregnancy. J Thromb Thrombolysis. 2013. doi: 10.1007/s11239-013-0941-9.Google Scholar
  33. 33.
    Eichinger S, Weltermann A, Philipp K. Prospective evaluation of hemostatic system activation and thrombin potential in healthy pregnant women with and without factor V Leiden. Thromb Haemost. 1999;82:1232–6.PubMedGoogle Scholar
  34. 34.
    Heit JA, Kobbervig CE, James AH. Trends in the incidence of venous thromboembolism during pregnancy or postpartum: a 30-year population-based study. Ann Intern Med. 2005;143:697–706.CrossRefPubMedGoogle Scholar
  35. 35.
    Te Raa DG, Ribbert LSM, Snijder RJ, Biesma DH. Treatment options in massive pulmonary embolism during pregnancy. A case-report and review of literature. Thromb Res. 2009;124:1–5.CrossRefGoogle Scholar
  36. 36.
    Turrentine MA, Braems G, Ramirez MM. Use of thrombolytics for the treatment of thromboembolic disease during pregnancy. Obstet Gynecol Surv. 1995;50:534–41.CrossRefPubMedGoogle Scholar
  37. 37.
    Leonhardt G, Gaul C, Nietsch HH. Thrombolytic therapy in pregnancy. J Thromb Thrombolysis. 2006;21:271–6.CrossRefPubMedGoogle Scholar
  38. 38.
    Holden EL, Ranu H, Sheth A. Thrombolysis for massive pulmonary embolism in pregnancy—a report of three cases and follow up over a two year period. Thromb Res. 2011;127:58–9.CrossRefPubMedGoogle Scholar
  39. 39.
    Fasullo S, Maringhini G, Terrazzino G. Thrombolysis for massive pulmonary embolism in pregnancy: a case report. Int J Emerg Med. 2011;4:69–74.PubMedCentralCrossRefPubMedGoogle Scholar
  40. 40.
    Jerjes-Sánchez C, Ramírez RA, Arriaga NR, Pimentel MG. Dosis altas e infusión rápida de estreptoquinasa para el tratamiento de tromboembolia pulmonar masiva. Arch Inst Cardiol Mex. 1993;63:227–34.PubMedGoogle Scholar
  41. 41.
    Jerjes-Sanchez C, Gutierrez-Fajardo P, Ramirez-Rivera A, Garcia ML, Hernández CHG. Infarto agudo del ventrículo derecho secundario a tromboembolia pulmonar masiva. Arch Inst Cardiol Mex. 1995;65:65–73.PubMedGoogle Scholar
  42. 42.
    Jerjes-Sanchez C, Ramirez-Rivera A, Garcia ML, Arriaga-Nava R, Valencia-Sanchez S, Rosado-Buzzo A, Pierzo JA, Rosas ME. Streptokinase and heparin versus heparin alone in massive pulmonary embolism: a randomized controlled trial. J Thromb Thrombolysis. 1995;2:67–9.CrossRefGoogle Scholar
  43. 43.
    Jerjes-Sanchez C, Ramirez-Rivera A, Arriaga-Nava R, Iglesias-Gonzalez S, Gutierrez P, Ibarra-Perez C, Martinez A, Valencia S, Rosado-Buzzo A, Pierzo JA, Rosas E. High dose and short-term streptokinase infusion in patients with pulmonary embolism. Prospective with seven-year follow-up trial. J Thromb Thrombolysis. 2001;12:237–47.CrossRefPubMedGoogle Scholar
  44. 44.
    Jerjes-Sanchez C, Villarreal-Umaña S, Ramirez-Rivera A, Garcia-Sosa A, Canseco LM, Archondo T, Reyes E, Garza A, Arriaga R, Castillo F, Jasso O, Garcia H, Bermudez M, Hernández JM, Garcia J, Martinez P, Rangel F, Gutierrez J, Comparan A. Improving adjunctive treatment in pulmonary embolism and fibrinolytic therapy. The role of enoxaparin and weight-adjusted unfractionated heparin. J Thromb Thrombolysis. 2009;27:154–62.CrossRefPubMedGoogle Scholar
  45. 45.
    Pollack CV. The use of oral anticoagulants for the treatment of venous thromboembolic events in an ED. Am J Emerg Med. 2014;32:1526–33.CrossRefPubMedGoogle Scholar
  46. 46.
    Sharifi M, Bay C, Schwartz F, Skrocki L. Safe-dose thrombolysis plus rivaroxaban for moderate and severe pulmonary embolism. Clin Cardiol. 2014;37:78–82.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2015

Authors and Affiliations

  1. 1.Instituto de Cardiologia y Medicina Vascular, TEC SaludSan Pedro Garza GarciaMexico
  2. 2.Escuela de Medicina, Tecnológico de MonterreySan Pedro Garza GarciaMexico
  3. 3.Unidad de Investigacion Clinica en Medicina SCMonterreyMexico
  4. 4.Department of Emergency RoomHospital de Cardiologia No. 34, Instituto Mexicano del Seguro SocialMonterreyMexico

Personalised recommendations